Yissum - Research Development Company of the Hebrew University

Computational Tool for the Design of Personalized Drug Cocktails, Based on Intra-Tumor Subpopulations

Posted by Yissum - Research Development Company of the Hebrew UniversityResponsive · Innovative Products and Technologies · Israel

Summary of the technology

A computational approach to map intra-tumor subpopulations for the rational design of individualized cancer drug cocktails
Project ID : 6-2019-7741

Description of the technology

Cancer research is moving into the frontiers of how to assign the correct drug(s) to a given patient. Cancer clinicians and researchers commonly search for overexpression of oncogenic biomarkers to assign a targeted treatment, but lack important information regarding the interplay between these markers and the response to therapy of the tumor-specific altered network. Furthermore certain cancer types, such as triple negative breast cancer, do not allow for the development of targeted drugs due to tremendous heterogeneity. Thus cytotoxic chemotherapy and/or radiotherapy remains the standard treatment of those cancers.
We propose a novel strategy, based on information theory resolves the intra-tumor molecular heterogeneity on the single cell level and allows to rationally design patient-specific treatments. The approach breaks down tumors into the subpopulations, and altered protein networks associated with each subpopulation. Targeting central proteins from the main altered networks, associated with each subpopulation, is essential in order to disturb the altered signaling in each tumor. Moreover, these networks can be used to rationally plan personalized sensitization of tumors to chemotherapy and/or radiotherapy.

The approach addresses individual patients, and in this way is superior to more common statistical analyses that divide the patient population into categories and then assign each patient to a predefined group.

Project manager

Shani Bullock
VP, Business Development, Healthcare

Project researchers

Nataly Kravchenko-Balasha
HUJI, Faculty of Dental Medicine
Institute of Dental Sciences

Related keywords

  • Medicine, Human Health
  • Biology / Biotechnology
  • Genome Research
  • Micro- and Nanotechnology related to Biological sciences
  • Recombinant DNA
  • Monoclonal Antibodies and Hybridomas
  • Gene Splicing and Manufacturing Equipment
  • Other Genetic Engineering
  • Molecular design Market
  • Microbiology Market
  • Micro- and Nanotechnology related to Biological sciences
  • Biochemistry / Biophysics Market
  • Toxicology Market
  • In vitro Testing, Trials Market
  • Stem cells and biobanks
  • Cellular and Molecular Biology Market
  • Population genetics Market
  • Gene Expression, Proteom Research Market
  • Bioinformatics Market
  • Enzymology/Protein Engineering/Fermentation
  • Genetic Engineering Market
  • Diagnostic
  • Therapeutic
  • Other Medical/Health Related
  • Agro and Marine biotech
  • Anatomy, Pathology, Immunology, Physiology
  • Clinical Medicine
  • Life Science & Biotechnology
  • bioinformatics

About Yissum - Research Development Company of the Hebrew University

Technology Transfer Office from Israel

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Founded in 1964 to protect and commercialize the Hebrew University’s intellectual property. Ranked among the top technology transfer companies, Yissum has registered over 8,900 patents covering 2,500 inventions; has licensed out 800 technologies and has spun-off 90 companies. Products that are based on Hebrew University technologies and were commercialized by Yissum generate today over $2 Billion in annual sales.

Send your request

By clicking "Send your request" you are signing up and accepting our Terms of Service and Privacy policy

Technology Offers on Innoget are directly posted and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.